2011
DOI: 10.1007/s00018-011-0633-6
|View full text |Cite
|
Sign up to set email alerts
|

Novel therapy for myocardial infarction: can HGF/Met be beneficial?

Abstract: Myocardial infarction (MI) is a leading cause of hospitalization worldwide. A recently developed strategy to improve the management of MI is based on the use of growth factors which are able to enhance the intrinsic capacity of the heart to repair itself or regenerate after damage. Among others, hepatocyte growth factor (HGF) has been proposed as a modulator of cardiac repair of damage due to the pleiotropic effects elicited by Met receptor stimulation. In this review we describe the mechanistic basis for auto… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
24
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 37 publications
(24 citation statements)
references
References 169 publications
0
24
0
Order By: Relevance
“…In a mouse model, TLR2 activation of neutrophils led to the release of MMP9, which was protective against experimentally-induced asthma [57]. HGF has been proposed as a modulator of cardiac tissue repair [58]. The expression of HGF and its secretion into the blood circulation are promoted during the early phase of myocardial infarction [59].…”
Section: Discussionmentioning
confidence: 99%
“…In a mouse model, TLR2 activation of neutrophils led to the release of MMP9, which was protective against experimentally-induced asthma [57]. HGF has been proposed as a modulator of cardiac tissue repair [58]. The expression of HGF and its secretion into the blood circulation are promoted during the early phase of myocardial infarction [59].…”
Section: Discussionmentioning
confidence: 99%
“…Several pathological conditions, including tumor growth, ischemia/reperfusion, diabetes, rheumatoid arthritis, atherosclerosis, and inflammatory processes also require neoangiogenesis. It is therefore not surprising that angiogenesis is therapeutically targeted in several human disorders (4,5).…”
mentioning
confidence: 99%
“…HGF has a cardioprotective role in experimentally induced myocardial infarction, preventing cardiomyocyte apoptosis, inducing angiogenesis, and improving impaired heart function (Aoki et al, 2000; Jayasankar et al, 2003; Sala and Crepaldi, 2011). …”
Section: Hgf and Igf1 In Cardiac Stem Cellsmentioning
confidence: 99%